Volume 25, Issue 1 (Jan 2023)
ARASENS: making sense out of first-line metastatic hormone-sensitive prostate cancer treatment
Jeanny B Aragon-Ching
Asian J Androl 25: 1-4; 10.4103/aja202230
Abstract |Full Text | PDF

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
Jeffrey J Leow1,2, Soon Hock Koh1,2, Marcus WL Chow1,2, Wayren Loke1, Rolando Salada1, Seok Kwan Hong1,2, Yuyi Yeow1,2, Chau Hung Lee2,3, Cher Heng Tan2,3, Teck Wei Tan1,2
Asian J Androl 25: 43-49; 10.4103/aja2021128
Abstract |Full Text | PDF

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml−1
Ma-Ping Huang1,2,3, Ping Tang1,2, Cliff S Klein3, Xing-Hua Wei2, Wei Du4, Jin-Gao Fu5, Tian-Hai Huang3, Hui Chen3, Ke-Ji Xie2
Asian J Androl 25: 82-85; 10.4103/aja202217
Abstract |Full Text | PDF

Radiomics based on biparametric MRI for the detection of significant residual prostate cancer after androgen deprivation therapy: using whole-mount histopathology as reference standard
Zhang-Zhe Chen1,2, Wei-Jie Gu2,3, Bing-Ni Zhou1,2, Wei Liu1,2, Hua-Lei Gan2,4, Yong Zhang5, Liang-Ping Zhou1,2, Xiao-Hang Liu1,2
Asian J Androl 25: 86-92; 10.4103/aja202215
Abstract |Full Text | PDF

New model of PIRADS and adjusted prostatespecific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study
Chen Huang1, Zong-Qiang Cai1, Feng Qiu1, Jin-Xian Pu1, Qi-Lin Xi1, Xue-Dong Wei1, Xi-Ming Wang2, Xiao-Jun Zhao1, Lin-Chuan Guo3, Jian-Quan Hou1, Yu-Hua Huang1
Asian J Androl 25: 126-131; 10.4103/aja202218
Abstract |Full Text | PDF

Age-related changes for the predictors of benign prostatic hyperplasia in Chinese men aged 40 years or older
Wei-Hao Shao1, Cai-Fang Zheng1, Yong-Chao Ge2, Xiao-Rui Chen1, Bo-Wen Zhang1, Gai-Li Wang1, Wei-Dong Zhang1
Asian J Androl 25: 132-136; 10.4103/aja202223
Abstract |Full Text | PDF

Volume 24, Issue 6 (Nov 2022)
The role of prostate-specific antigen density and negative multiparametric magnetic resonance imaging in excluding prostate cancer for biopsy-naïve men: clinical outcomes from a high-volume center in China
Chi-Chen Zhang1, Xiang Tu1, Tian-Hai Lin1, Di-Ming Cai2, Ling Yang3, Ling Nie4, Shi Qiu1, Zhen-Hua Liu1, Kun Jin1, Jia-Kun Li1, Xing-Yu Xiong1, Lu Yang1, Qiang Wei1
Asian J Androl 24: 615-619; 10.4103/aja202220
Abstract |Full Text | PDF

LncRNA GAS5 enhances tumor stem cell-like medicated sensitivity of paclitaxel and inhibits epithelial-to-mesenchymal transition by targeting the miR-18a-5p/STK4 pathway in prostate cancer
Ting-Ting Lu1,2, Xia Tao3, Hua-Lei Li4, Ling Gai5, Hua Huang6, Feng Li1
Asian J Androl 24: 643-652; 10.4103/aja2021117
Abstract |Full Text | PDF

A correlative study of iron metabolism based on q-Dixon MRI in benign prostatic hyperplasia and prostate cancer
Zhen Tian1, Yong-Gang Li2, Guang-Zheng Li2, Zhi-Hao Huang1, Wen-Hao Dai1, Xue-Dong Wei1, Wei-Jie Zhang1, Zhen-Yu Fu3, Yu-Hua Huang1
Asian J Androl 24: 671-674; 10.4103/aja2021116
Abstract |Full Text | PDF

Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression
Yue-Mei Hu1,2,3, Xiao-Li Lou1,3, Bao-Zhu Liu3,4, Li Sun5, Shan Wan1, Lei Wu5, Xin Zhao1, Qing Zhou6, Mao-Min Sun5, Kun Tao2, Yong-Sheng Zhang7, Shou-Li Wang1,8
Asian J Androl 24: 684-684; 10.4103/aja202285
Full Text | PDF